Eli Lilly Alzheimer’s drug to be blocked for use by NHS, The Telegraph reports
(Reuters) -Eli Lilly’s treatment for early Alzheimer’s is expected to be blocked for use by Britain’s National Health Service (NHS),…
Exclusive-Top U.S. general makes unannounced Middle East trip as Iran threat looms
By Phil Stewart AMMAN (Reuters) – The top U.S. general began an unannounced visit to the Middle East on Saturday…
Microsoft to host cybersecurity summit after CrowdStrike-induced IT outage
(Reuters) -Microsoft said on Friday it would hold a summit in September on improving cybersecurity systems, after a faulty update…
Analysis-Fed’s dovish shift a mixed blessing for BOJ rate hike plan
By Leika Kihara JACKSON HOLE, Wyoming (Reuters) – The U.S. Federal Reserve’s dovish shift will likely give the Bank of…
Musk’s Neuralink says second trial implant went well, no thread retraction issue
(Reuters) – Elon Musk’s brain technology startup Neuralink said its implant, designed to allow paralyzed patients to use digital devices…
J&J in talks with holdouts to $6.5 billion talc settlement
By Dietrich Knauth and Mike Spector NEW YORK (Reuters) – Johnson & Johnson said on Friday it is negotiating with…
Amazon must face D.C.’s antitrust lawsuit, appeals court rules
By Jody Godoy (Reuters) – An appeals court in Washington, D.C. revived the district’s lawsuit against Amazon.com Inc on Thursday,…
Exclusive-Evolent Health in sale talks after receiving takeover interest, sources say
By Milana Vinn and Anirban Sen NEW YORK (Reuters) -Evolent Health is in talks with private equity firms and healthcare…
Analysis-Walmart tears up China online strategy with JD.com stake sale
By Siddharth Cavale NEW YORK (Reuters) – Walmart’s stake in Chinese e-commerce firm JD.com was once central to its China…
Target raises 2024 profit forecast as price cuts draw shoppers
By Ananya Mariam Rajesh, Siddharth Cavale (Reuters) -Target raised its full-year profit forecast on Wednesday and reported its first increase…